You are here

Home » Content

Normal CD4 Sayılı HIV Pozitif Bir Hastada Fournier Gangreni

Fournier's Gangrene at HIV Positive Patient with Normal CD4 Count

Journal Name:

  • Abant Tıp Dergisi

Publication Year:

  • 2014

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Fournier's gangrene mainly seen in men is rapidly progressi-ve necrotizing fasciitis and has a high mortality rate. Altho-ugh the etiology of Fournier's gangrene is similar to the show soft tissue infections, the disease especially could be morta-lity in patients with immunosuppressive and diabetes. The main factors in treatment of the disease are early diagnosis, surgical debridement and appropriate antibiotics. In this article we aimed to present developing Fournier’s gangrene in a patient with human immunedeficiency virus (HIV) positi-ve after iskiorectal abscess drainage and intended to high-light the need for early surgical debridement.
Bookmark/Search this post with
Abstract (Original Language): 
Fournier gangreni, ağırlıklı olarak erkeklerde görülen, hızlı ilerleyen, mortalite oranı yüksek bir nekrotizan fasiittir. Yumuşak doku enfeksiyonları ile benzer etiyoloji gösterme-sine karşın özellikle immünsüpressif ve diabetli hastalarda hastalık çok daha hızlı seyir göstererek mortal seyreder. Hastalığın tedavisinde ana unsurlar erken tanı, erken cerra-hi debritman ve uygun antibiyoterapidir. Bu çalışma predis-pozan faktör olarak insan immün yetmezlik virusu (HIV) pozitifliği olan bir hastada iskiorektal apse drenajı sonrasın-da Fournier gangreni gelişimini aktarmak ve bu hastalarda erken cerrahi debritmanın gerekliliğini vurgulamak amaç-lanmıştır.
FULL TEXT (PDF): 
PDF icon arastirmax-normal-cd4-sayili-hiv-pozitif-bir-hastada-fournier-gangreni.pdf
  • 2
180
182
  • Turkish

REFERENCES

References: 

1. Thwaini A, Khan A, Malik A, Cherian J, Barua J, Shergill I, Mammen K. Fournier's gangrene and its emergency management. Postgrad Med J 2006; 82(970): 516-9.
2. Morpurgo E, Galandiuk S. Fournier's gangrene. Surg Clin North Am 2002; 82(6): 1213-24.
3. Sroczyński M, Sebastian M, Rudnicki J, Sebastian A, Agrawal AK. A complex approach to the treat-ment of Fournier's gangrene. Adv Clin Exp Med. 2013 Jan-Feb;22(1):131-5.
4. Bjurlin MA, O'Grady T, Kim DY, Divakaruni N, Drago A, Blumetti J, Hollowell CM. Causative patho-gens, antibiotic sensitivity, resistance patterns, and severity in a contemporary series of Fournier's gangrene. Urology. 2013 Apr;81(4):752-8. doi: 10.1016/j.urology.2012.12.041. Epub 2013 Feb 20.
5. Romeo DY, Hervías EA, Lafuente CB, Peña MTM, Sinués EM, Toledo LS. Fournıer ́s Gangrene In A 44-Year-Old Woman: Ct Scan Fındıngs. Arch. Esp. Urol. 2009; 62 (6): 483-5
6. Ndirika SC, Melville R, Green J. Fournier’s gang-rene in a man who was HIV-positive with a high CD4 count. UroToday International Journal;2010;3(5):1-10.
7. Elem B, Ranjan P. Impact of immunodeficiency virus (HIV) on Fournier's gangrene: observations in Zambia. Ann R Coll Surg Engl 1995; 77: 283-6.
8. Benjelloun el B, Souiki T, Yakla N, Ousadden A, Mazaz K, Louchi A, Kanjaa N, Taleb KA. Fournier's gangrene: our experience with 50 patients and analysis of factors affecting mortality. World J Emerg Surg. 2013 Apr 1;8(1):13. doi: 10.1186/1749-7922-8-13.
9. Sroczyński M, Sebastian M, Rudnicki J, Sebastian A, Agrawal AK. A complex approach to the treat-ment of Fournier's gangrene. Adv Clin Exp Med. 2013 Jan-Feb;22(1):131-5.
10. Altarac S, Katušin D, Crnica S, Papeš D, Rajković Z, Arslani N. Fournier's gangrene: etiology and out-come analysis of 41 patients. Urol Int 2012; 88(3): 289-93.

Thank you for copying data from http://www.arastirmax.com